Enhanced ACKR3 expression in numerous cancer types (e.g., glioma, lung, breast, colorectal, lymphoma), has been associated with the shaping of CXCL12 gradients, by internalizing with the chemokine and recycling the receptor back to the plasma membrane24. This evidence concerns the gene ACKR3 and glioma.